Offer - Urjas Oil for just ₹ 1 X
Telmikind Beta 25 Mg Tablet, a prescription drug, is manufactured in various forms such as Tablet. Telmikind Beta 25 Mg Tablet also has some secondary and off-label uses. These are listed below.
The right dosage of Telmikind Beta 25 Mg Tablet depends on the age, gender, and medical history of the patient. The condition it has been prescribed for, and the route of administration also determine the right dosage. Refer to the dosage section for a detailed discussion.
Telmikind Beta 25 Mg Tablet also has some side effects, the most common being Headache, Dizziness, Weakness. Apart from the aforementioned side effects, Telmikind Beta 25 Mg Tablet can also lead to other problems, which have been listed below. These side effects of Telmikind Beta 25 Mg Tablet are usually temporary and subside with the completion of treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
Furthermore, you should know that effect of Telmikind Beta 25 Mg Tablet is Severe for pregnant women and Safe for women who are breastfeeding. Warnings related to Telmikind Beta 25 Mg Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Telmikind Beta 25 Mg Tablet is not recommended if you suffer from certain medical conditions as it can have adverse effects. Diabetes, Congestive Heart Failure (CHF), Angioedema are examples of such conditions.
Drug interactions for Telmikind Beta 25 Mg Tablet have been reported in the medical literature. Refer to the list below for further details.
You should also be aware that Telmikind Beta 25 Mg Tablet is not safe while driving, and is not addiction.
Telmikind Beta 25 Mg Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
Adult |
|
Geriatric |
|
Is the use of Telmikind Beta 25 Mg Tablet safe for pregnant women?
Telmikind Beta has many dangerous side effects in pregnant women. If you are pregnant, do not consume Telmikind Beta without medical advice.
Is the use of Telmikind Beta 25 Mg Tablet safe during breastfeeding?
Telmikind Beta is safe for breastfeeding women.
What is the effect of Telmikind Beta 25 Mg Tablet on the Kidneys?
Telmikind Beta may cause harmful effects on kidney. if you feel its having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Telmikind Beta 25 Mg Tablet on the Liver?
The liver can be affected by Telmikind Beta. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Telmikind Beta only after medical advice.
What is the effect of Telmikind Beta 25 Mg Tablet on the Heart?
Telmikind Beta has very mild side effects on the heart.
If you are suffering from any of the following diseases, you should not take Telmikind Beta 25 Mg Tablet unless your doctor advises you to do so -
Is this Telmikind Beta 25 Mg Tablet habit forming or addictive?
No, you will not get addicted to Telmikind Beta 25 Mg Tablet.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Telmikind Beta 25 Mg Tablet as you may feel sleepy.
Is it safe?
Telmikind Beta 25 Mg Tablet should be used only after doctor's advice.
Is it able to treat mental disorders?
No, Telmikind Beta 25 Mg Tablet is not used to treat mental disorders.
Interaction between Food and Telmikind Beta 25 Mg Tablet
There is no information on the effects of taking Telmikind Beta 25 Mg Tablet with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Telmikind Beta 25 Mg Tablet
It is difficult to say anything about the effect of Telmikind Beta 25 Mg Tablet and alcohol. No research has been done on this yet.
Yes, Telmikind Beta causes hyperkalemia (high amount of potassium in the blood). Therefore, monitoring of blood potassium levels is important during Telmikind Beta therapy.
No, Telmikind Beta is not a beta blocker/calcium channel blocker/diuretic/blood thinner/ace inhibitor. It is angiotensin II receptor blocker (an antihypertensive drug).
Yes, Telmikind Beta may cause a cough on rare occasions. If you experience a cough while taking Telmikind Beta, please talk to your doctor immediately.
Telmikind Beta is available in the form of tablets. A tablet is usually taken once a day, with or without food because food affects the absorption of this drug. It should be taken at exactly the same time every time to avoid skipping the dose. Telmikind Beta might start showing the effects between 2 to 4 weeks, therefore, it is important to continue taking it even when you feel well. One should take Telmikind Beta exactly as prescribed by their doctor.
Yes, Telmikind Beta causes hyponatremia (low level of sodium in the blood). Treatment with telmisartan might call for a regular blood monitoring for checking sodium levels.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lopressor (metoprolol tartrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 148-149
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 847-850